Journal
PATHOBIOLOGY
Volume 86, Issue 1, Pages 14-23Publisher
KARGER
DOI: 10.1159/000490727
Keywords
Myelodysplastic syndromes; Flow cytometry; Diagnosis
Categories
Ask authors/readers for more resources
Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS. (C) 2018 The Author(s) Published by S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
